Literature DB >> 7671645

Pathogenesis of traveler's diarrhea.

H L DuPont1.   

Abstract

Diarrhea is the most common medical complication among persons venturing into tropical and semitropical regions of the developing world from industrialized regions. The illness is characteristically caused by one of a variety of bacterial agents, of which enterotoxigenic Escherichia coli is the most important. Intestinal electrolyte fluid movement explains the pathophysiology of most cases while in certain situations osmotic diarrhea or altered intestinal motility may lead to passage of unformed stools. In 1-2% of traveler, diarrhea lasts more than 1 month. Most of the patients will have diarrhea that is eventually self-limiting. The cause and mechanisms of diarrhea in these settings are largely unknown although a focal intestinal inflammation lesion may be found.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671645     DOI: 10.1159/000239395

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  5 in total

1.  Diarrhea in the International Traveler.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

2.  Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.

Authors:  Clayton Harro; Subhra Chakraborty; Andrea Feller; Barbara DeNearing; Alicia Cage; Malathi Ram; Anna Lundgren; Ann-Mari Svennerholm; August L Bourgeois; Richard I Walker; David A Sack
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

Review 3.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Lactobacillus reuteri strains protect epithelial barrier integrity of IPEC-J2 monolayers from the detrimental effect of enterotoxigenic Escherichia coli.

Authors:  Shokoufeh Karimi; Hans Jonsson; Torbjörn Lundh; Stefan Roos
Journal:  Physiol Rep       Date:  2018-01

5.  Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology.

Authors:  Jason W Sahl; Jeticia R Sistrunk; Nabilah Ibnat Baby; Yasmin Begum; Qingwei Luo; Alaullah Sheikh; Firdausi Qadri; James M Fleckenstein; David A Rasko
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.